207 related articles for article (PubMed ID: 29025138)
1. Relative Bioavailability, Intranasal Abuse Potential, and Safety of Benzhydrocodone/Acetaminophen Compared with Hydrocodone Bitartrate/Acetaminophen in Recreational Drug Abusers.
Guenther SM; Mickle TC; Barrett AC; Roupe KA; Zhou J; Lam V
Pain Med; 2018 May; 19(5):955-966. PubMed ID: 29025138
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and Abuse Potential of Benzhydrocodone, a Novel Prodrug of Hydrocodone, After Intranasal Administration in Recreational Drug Users.
Mickle TC; Guenther SM; Barrett AC; Roupe KA; Zhou J; Dickerson D; Webster LR
Pain Med; 2018 Dec; 19(12):2438-2449. PubMed ID: 29092079
[TBL] [Abstract][Full Text] [Related]
3. Human abuse potential of immediate-release/extended-release versus immediate-release hydrocodone bitartrate/acetaminophen: a randomized controlled trial in recreational users of prescription opioids.
Devarakonda K; Kostenbader K; Zheng Y; Montgomery JB; Barrett T; Young JL; Webster LR
Postgrad Med; 2015 Jan; 127(1):13-21. PubMed ID: 25584931
[TBL] [Abstract][Full Text] [Related]
4. Intranasal Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users.
Harris SC; Cipriano A; Colucci SV; Kapil RP; Geoffroy P; Hopyan T; Levy-Cooperman N
Pain Med; 2016 May; 17(5):820-31. PubMed ID: 26814240
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Relative Intranasal Abuse Potential of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users.
Bond M; Schoedel KA; Rabinovich-Guilatt L; Gasior M; Tracewell W; Malamut R; Ma Y; Webster LR
Pain Med; 2018 Aug; 19(8):1597-1612. PubMed ID: 29016880
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, placebo-controlled study of the efficacy and safety of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen tablets for acute postoperative pain.
Singla N; Margulis R; Kostenbader K; Zheng Y; Barrett T; Giuliani MJ; Chen Y; Young JL
Phys Sportsmed; 2015 May; 43(2):126-37. PubMed ID: 25796986
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, single-dose comparison of the analgesic efficacy of tramadol/acetaminophen combination tablets, hydrocodone/acetaminophen combination tablets, and placebo after oral surgery.
Fricke JR; Karim R; Jordan D; Rosenthal N
Clin Ther; 2002 Jun; 24(6):953-68. PubMed ID: 12117085
[TBL] [Abstract][Full Text] [Related]
8. Oral Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users.
Harris SC; Cipriano A; Colucci SV; Kapil RP; Geoffroy P; Hopyan T; Levy-Cooperman N
Pain Med; 2017 Jul; 18(7):1278-1291. PubMed ID: 27651514
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of hydrocodone extended-release tablets formulated with different levels of coating to achieve abuse deterrence compared with a hydrocodone immediate-release/acetaminophen tablet in healthy subjects.
Darwish M; Bond M; Tracewell W; Robertson P; Yang R
Clin Drug Investig; 2015 Jan; 35(1):13-22. PubMed ID: 25391549
[TBL] [Abstract][Full Text] [Related]
10. Abuse Potential with Oral Route of Administration of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users.
Darwish M; Bond M; Ma Y; Tracewell W; Robertson P; Webster LR
Pain Med; 2017 Jan; 18(1):61-77. PubMed ID: 27330154
[TBL] [Abstract][Full Text] [Related]
11. Intranasal abuse potential of an abuse-deterrent oxycodone formulation compared to oxycodone immediate release and placebo in nondependent, recreational opioid users.
Setnik B; Schoedel K; Bartlett C; Dick C; Hakim N; Geoffroy P
J Opioid Manag; 2017; 13(6):449-464. PubMed ID: 29308591
[TBL] [Abstract][Full Text] [Related]
12. Tolerability of Biphasic-Release Hydrocodone Bitartrate/Acetaminophen Tablets (MNK-155): A Phase III, Multicenter, Open-Label Study in Patients With Osteoarthritis or Chronic Low Back Pain.
Zheng Y; Kostenbader K; Barrett T; Hisaw E; Giuliani MJ; Chen Y; Young JL
Clin Ther; 2015 Jun; 37(6):1235-47. PubMed ID: 25913923
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of once-daily, extended-release hydrocodone in individuals previously receiving hydrocodone/acetaminophen combination therapy for chronic pain.
Bartoli A; Michna E; He E; Wen W
Postgrad Med; 2015 Jan; 127(1):5-12. PubMed ID: 25526227
[TBL] [Abstract][Full Text] [Related]
14. Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials.
Devarakonda K; Kostenbader K; Giuliani MJ; Young JL
BMC Pharmacol Toxicol; 2015 Nov; 16():31. PubMed ID: 26614499
[TBL] [Abstract][Full Text] [Related]
15. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.
Litkowski LJ; Christensen SE; Adamson DN; Van Dyke T; Han SH; Newman KB
Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815
[TBL] [Abstract][Full Text] [Related]
16. Prevention of Opioid-Induced Nausea and Vomiting During Treatment of Moderate to Severe Acute Pain: A Randomized Placebo-Controlled Trial Comparing CL-108 (Hydrocodone 7.5 mg/Acetaminophen 325 mg/Rapid-Release, Low-Dose Promethazine 12.5 mg) with Conventional Hydrocodone 7.5 mg/Acetaminophen 325 mg.
Zuniga JR; Papas AS; Daniels SE; Patrick K; Muse DD; Oreadi D; Giannakopoulos HE; Granquist EJ; Levin LM; Chou JC; Maibach H; Schachtel BP
Pain Med; 2019 Dec; 20(12):2528-2538. PubMed ID: 30657996
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and Pharmacodynamic Correlations From 2 Studies Evaluating Abuse Potential of Hydrocodone Extended-Release Tablets.
Schoedel KA; Gillespie M; Levy-Cooperman N; Shram MJ; Rabinovich-Guilatt L
Clin Pharmacol Drug Dev; 2019 Jan; 8(1):32-39. PubMed ID: 29723441
[TBL] [Abstract][Full Text] [Related]
18. Single- and multiple-dose pharmacokinetics of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) compared with immediate-release hydrocodone bitartrate/ibuprofen and immediate-release tramadol HCl/acetaminophen.
Devarakonda K; Kostenbader K; Giuliani MJ; Young JL
J Pain Res; 2015; 8():647-56. PubMed ID: 26508885
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and Abuse Potential of Asalhydromorphone, a Novel Prodrug of Hydromorphone, After Intranasal Administration in Recreational Drug Users.
Guenther S; Mickle TC; Barrett AC; Smith A; Braeckman R; Kelsh D; Vince B
Pain Med; 2020 Mar; 21(3):511-520. PubMed ID: 30986302
[TBL] [Abstract][Full Text] [Related]
20. Assessing subjective and physiologic effects following intranasal administration of a new formulation of immediate release oxycodone HCl (Oxecta™) tablets in nondependent recreational opioid users.
Schoedel KA; Rolleri RL; Faulknor JY; Pixton GC; Chen N; Bass A; Sommerville KW; Sellers E
J Opioid Manag; 2012; 8(5):315-27. PubMed ID: 23247908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
